Technical Analysis for GBIO - Generation Bio Co.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | N/A | Down | Down |
Historical GBIO trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Doji - Bullish? | Reversal | 0.00% | |
Multiple of Ten Bullish | Other | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
20 DMA Support | Bullish | -1.18% | |
Inside Day | Range Contraction | -1.18% | |
Wide Bands | Range Expansion | -1.18% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
60 Minute Opening Range Breakdown | about 19 hours ago | |
10 DMA Resistance | about 19 hours ago | |
20 DMA Resistance | about 20 hours ago | |
Down 3% | about 20 hours ago | |
Down 2 % | about 20 hours ago |
Get a Trading Assistant
- Earnings date: ???
Generation Bio Co. Description
Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company is designing therapies to provide targeted delivery of genetic payloads that include large and multiple genes across a broad array of tissues, and to be redosable for individualized and extended treatment throughout a patient’s life. The platform is designed to expand access to treatments for rare diseases and to address prevalent diseases through efficient, scalable manufacturing.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Rare Diseases Emerging Technologies Molecular Biology Gene Therapy Manufacturing Process Lipid Applied Genetics Gene Delivery
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 55.72 |
52 Week Low | 17.0 |
Average Volume | 537,160 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 34.83 |
20-Day Moving Average | 30.39 |
10-Day Moving Average | 30.54 |
Average True Range | 3.26 |
ADX | 19.08 |
+DI | 20.51 |
-DI | 22.17 |
Chandelier Exit (Long, 3 ATRs ) | 25.70 |
Chandelier Exit (Short, 3 ATRs ) | 32.58 |
Upper Bollinger Band | 36.71 |
Lower Bollinger Band | 24.06 |
Percent B (%b) | 0.49 |
BandWidth | 41.62 |
MACD Line | -0.85 |
MACD Signal Line | -1.32 |
MACD Histogram | 0.4735 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 32.65 | ||||
Resistance 3 (R3) | 32.57 | 31.68 | 32.25 | ||
Resistance 2 (R2) | 31.68 | 31.07 | 31.73 | 32.12 | |
Resistance 1 (R1) | 30.97 | 30.69 | 30.53 | 31.05 | 31.98 |
Pivot Point | 30.08 | 30.08 | 29.86 | 30.13 | 30.08 |
Support 1 (S1) | 29.37 | 29.47 | 28.93 | 29.45 | 28.52 |
Support 2 (S2) | 28.48 | 29.09 | 28.53 | 28.38 | |
Support 3 (S3) | 27.77 | 28.48 | 28.25 | ||
Support 4 (S4) | 27.85 |